[ TRANSACTION RECORD ]

Sanofi Investment in Rare Disease Therapeutics — 2026

VERIFIED VECTOR ID: 002701 · tx-416
M SOURCE NODE — FUNDER
Sanofi
Healthcare France
$1,700,000,000
EQUITY
30/05/2026
Q DESTINATION NODE — RECIPIENT
Rare Disease Therapeutics
SPV France
Amount (USD)
$1.7B
Flow Type
EQUITY
Transaction Date
30/05/2026
Primary Source
View Filing ↗
Funder Profile [ M ]
Entity Sanofi
AUM 140000
HQ Location France
Sector Healthcare
Recipient Profile [ Q ]
Entity Rare Disease Therapeutics
Entity Type SPV
Jurisdiction France
Intelligence Note

Sanofi finalized a 1.7 billion dollar equity investment to build the Rare Disease Therapeutics manufacturing facility in France to produce specialized biologic medicines. This transaction supports the global supply chain for orphan drugs and genetic therapies for patients. The deal represents a strategic institutional investment in high-margin pharmaceutical platforms.

Σ
Primary Forensic Source https://www.sanofi.com/en/media-room/press-releases/2026/sanofi-rare-disease-manufacturing-investment/
✓ SOURCE LINKED